Genmab A/S (DE:GE9)
BERLIN:GE9
Holding DE:GE9?
Track your performance easily

Genmab A/S (GE9) Technical Analysis

9 Followers

Summary of all the Indicators

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Genmab A/S’s (GE9) Moving Averages Convergence Divergence (MACD) indicator is -1.96, suggesting Genmab A/S is a Sell.
Genmab A/S’s (GE9) 20-Day exponential moving average is 212.52, while Genmab A/S’s (GE9) share price is €217.7, making it a Buy.
Genmab A/S’s (GE9) 50-Day exponential moving average is 220.23, while Genmab A/S’s (GE9) share price is €217.7, making it a Sell.

Genmab A/S (GE9) Pivot Points

Nov 12, 2024, 09:26 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
209.00
210.30
212.60
213.90
216.20
217.50
219.80
Fibonacci
210.30
211.68
212.52
213.90
215.28
216.12
217.50
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Genmab A/S (GE9) Moving Averages

Nov 12, 2024, 09:26 PM
Period
Simple
Exponential
MA5
211.94Buy
213.45Buy
MA10
210.47Buy
211.95Buy
MA20
210.94Buy
212.52Buy
MA50
221.34Sell
220.23Sell
MA100
233.75Sell
231.34Sell
MA200
249.79Sell
247.45Sell
Genmab A/S’s (GE9) 10-Day exponential moving average is 211.95, while Genmab A/S’s (GE9) share price is €217.7, making it a Buy.
Genmab A/S’s (GE9) 100-Day exponential moving average is 231.34, while Genmab A/S’s (GE9) share price is €217.7, making it a Sell.
Genmab A/S’s (GE9) stock price is €217.7 and Genmab A/S’s (GE9) 50-day simple moving average is 221.34, creating a Sell signal.
Genmab A/S’s (GE9) stock price is €217.7 and Genmab A/S’s (GE9) 100-day simple moving average is 233.75, creating a Sell signal.
Genmab A/S’s (GE9) stock price is €217.7 and Genmab A/S’s (GE9) 200-day simple moving average is 249.79, creating a Sell signal.

Genmab A/S (GE9) Technical Indicators

Nov 12, 2024, 09:26 PM
Name
Value
Implied Action
RSI (14)
56.50
Neutral
STOCH (9,6)
75.54
Neutral
STOCHRSI (14)
60.07
Neutral
MACD (12,26)
-1.96
Sell
ADX (14)
26.37
Neutral
Williams %R
-25.67
Buy
CCI (14)
174.62
Sell
ATR (14)
4.88
-
Ultimate Oscillator
65.25
Neutral
ROC
4.11
Buy
Genmab A/S’s (GE9) Relative Strength Index (RSI) is 56.50, creating a Neutral signal.
Genmab A/S’s (GE9) Trend Strength Indicator (ADX) is 26.37, creating a Neutral signal.
Genmab A/S’s (GE9) Commodity Channel Index (CCI) is 174.62, creating a Sell signal.
Genmab A/S’s (GE9) Price Rate of Change (ROC) is 4.11, creating a Buy signal.

FAQ

Is GE9 a Buy, Hold, or Sell?
Based on GE9’s technical indicators, GE9 is a Hold.
    What is GE9’s RSI (14)?
    GE9’s RSI (14) is 56.50, which suggests GE9 is a Neutral.
      What is GE9’s MACD?
      GE9’s MACD is -1.96, which suggests GE9 is a Sell.
        What is GE9’s 5-day moving average?
        GE9’s 5-day moving average is 211.94, which suggests GE9 is a Buy.
          What is GE9’s 20-day moving average?
          GE9 20-day moving average is 210.94, which suggests GE9 is a Buy.
            What is GE9’s 50-day moving average?
            GE9’s 50-day moving average is 221.34, which suggests GE9 is a Sell.
              What is GE9’s 200-day moving average?
              GE9’s 200-day moving average is 249.79, which suggests GE9 is a Sell.
                What is GE9’s Williams % R (14)?
                GE9’s Williams % R (14) is -25.67, which suggests GE9 is a Buy.
                  What is GE9’s CCI (14)?
                  GE9’s CCI (14) is 174.62, which suggests GE9 is a Sell.
                    What is the share price of Genmab A/S?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis